This morning, Chemours discussed its dismal financial performance during its Q4 Quarterly Earnings Call. Chemours’ leadership failed to provide clarity on the growth of C-8 and environmental liabilities, the company’s recent highly critical evaluation from Moody’s, how thousands of victims of C-8 contamination will be compensated and have their water filtered, and other crucial issues. The… Read More

On Wednesday, Chemours will hold its Q4 Earnings Call as it faces increased scrutiny amid mounting liabilities and a bleak financial outlook. The viability of the company, which was spun off from DuPont in July 2015, continues to be tested as it attempts to manage billions of dollars’ worth of potential liabilities that were transferred to… Read More

Today, Keep Your Promises DuPont announced that it has retained Donald Baker of Baker & Miller PLLC to help devise an antitrust challenge to the proposed merger of DuPont and Dow Chemical. This effort is designed to encourage antitrust enforcement from the U.S. Department of Justice or the U.S. Federal Trade Commission (depending on which… Read More

DuPont will discuss its financial performance during its Q4 Quarterly Earnings Call on Tuesday, January 26, 2016 (listeners can access the call by visiting investors.dupont.com). The Q4 call presents an important opportunity to question DuPont’s executive leadership on pressing issues for the company, including the continued decline of Chemours that would lead to billions of… Read More

Keep Your Promises DuPont advisor Harold Bock released this statement in response to Tuesday’s news regarding merger talks between DuPont and Dow Chemical: “Yesterday’s news, while significant, comes as no surprise to those who have been fighting for justice from DuPont since 2001. After decades of covering up the dangers of C-8 and fighting accountability… Read More

Keep Your Promises DuPont advisor Dr. Paul Brooks released this statement in response to Chemours’ Form 8-K SEC filing dated November 12, 2015: “Chemours’ disclosure to the SEC on Thursday is an acknowledgement of the company’s liabilities, and we are glad to see the company taking a step in the right direction in responding to… Read More

This morning, Chemours discussed its financial performance during its Q3 Quarterly Earnings Call. Faced with clear and significant liabilities in connection to C-8 contamination, Chemours leadership gave no indication that the company has accrued for these costs while baselessly downplaying the possibility of punitive damage awards in the upcoming bellwether trials and incorrectly stating that the… Read More

PARKERSBURG, WV – Tomorrow, Chemours will discuss its financial performance during its Q3 Quarterly Earnings Call (listeners can access the call by visiting investors.chemours.com). Chemours is a company saddled with massive debt, exposure to billions of dollars in lawsuits and remediation obligations, mounting defense costs related to ongoing litigation, and declining profitability and cash flow. “Chemours’… Read More

PARKERSBURG, WV – Today, Keep Your Promises advisor Harold Bock issued a statement on behalf of the campaign applauding the jury’s verdict in favor of plaintiff Carla Bartlett in the first DuPont C-8 bellwether trial: “We at Keep Your Promises are thrilled by the jury’s decision in this case. While this verdict is just a… Read More

PARKERSBURG, WV – Today, Keep Your Promises issued a statement from advisor Joe Kiger regarding DuPont CEO Ellen Kullman’s impending resignation: “While this news is not unexpected given the reckless spinoff of DuPont’s Specialty Chemicals division and CEO Kullman’s handling of the C-8 issue in our communities, Ms. Kullman’s resignation does not let DuPont off… Read More